CLINICAL_TRIALS
trial_result
· 2012-04-23
Clinical Trial Update: Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis [Phase 4]
Summary
Phase 4 study evaluating etanercept for moderate-to-severe psoriasis has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Plaque Psoriasis, Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2012-04-23